Clinical Development Programs for Chronic Idiopathic Urticaria Indication for H1-antihistamines

5/14/02


Click here to start


Table of Contents

Clinical Development Programs for Chronic Idiopathic Urticaria Indication for H1-antihistamines

Outline

Types of Urticaria

Clinical Features of CIU

Clinical Program for CIU Indication

Patients Enrolled in CIU Studies

Patients Enrolled in CIU Studies

Primary Efficacy Variables

Secondary Efficacy Variables

Safety Assessment

Outline

Loratadine Clinical Program

Loratadine Study C87-056

Loratadine Study C87-056

Loratadine Study C86-044

Loratadine Study C86-044

Loratadine Study C88-067

Desloratadine Clinical Program

Cetirizine Clinical Program

Fexofenadine Clinical Program

Prescription Drugs Marketed in the US for the Treatment of Urticaria

OTC Drugs for Urticaria

Concluding Remarks

Author: Badrul A. Chowdhury